TY - JOUR
T1 - Data standards for atrial fibrillation/flutter and catheter ablation
T2 - the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
AU - Batra, Gorav
AU - Aktaa, Suleman
AU - Camm, A. John
AU - Costa, Francisco
AU - Di Biase, Luigi
AU - Duncker, David
AU - Fauchier, Laurent
AU - Fragakis, Nikolaos
AU - Frost, Lars
AU - Hijazi, Ziad
AU - Juhlin, Tord
AU - Merino, José L.
AU - Mont, Lluis
AU - Nielsen, Jens C.
AU - Oldgren, Jonas
AU - Polewczyk, Anna
AU - Potpara, Tatjana
AU - Sacher, Frederic
AU - Sommer, Philipp
AU - Tilz, Roland
AU - Maggioni, Aldo P.
AU - Wallentin, Lars
AU - Casadei, Barbara
AU - Gale, Chris P.
N1 - Publisher Copyright:
© 2022 The Author(s).
PY - 2023/9/1
Y1 - 2023/9/1
N2 - Aims: Standardized data definitions are essential for monitoring and assessment of care and outcomes in observational studies and randomized controlled trials (RCTs). The European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart) project of the European Society of Cardiology aimed to develop contemporary data standards for atrial fibrillation/flutter (AF/AFL) and catheter ablation. Methods and results: We used the EuroHeart methodology for the development of data standards and formed a Working Group comprising 23 experts in AF/AFL and catheter ablation registries, as well as representatives from the European Heart Rhythm Association and EuroHeart. We conducted a systematic literature review of AF/AFL and catheter ablation registries and data standard documents to generate candidate variables. We used a modified Delphi method to reach a consensus on a final variable set. For each variable, the Working Group developed permissible values and definitions, and agreed as to whether the variable was mandatory (Level 1) or additional (Level 2). In total, 70 Level 1 and 92 Level 2 variables were selected and reviewed by a wider Reference Group of 42 experts from 24 countries. The Level 1 variables were implemented into the EuroHeart IT platform as the basis for continuous registration of individual patient data. Conclusion: By means of a structured process and working with international stakeholders, harmonized data standards for AF/AFL and catheter ablation for AF/AFL were developed. In the context of the EuroHeart project, this will facilitate country-level quality of care improvement, international observational research, registry-based RCTs, and post-marketing surveillance of devices and pharmacotherapies.
AB - Aims: Standardized data definitions are essential for monitoring and assessment of care and outcomes in observational studies and randomized controlled trials (RCTs). The European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart) project of the European Society of Cardiology aimed to develop contemporary data standards for atrial fibrillation/flutter (AF/AFL) and catheter ablation. Methods and results: We used the EuroHeart methodology for the development of data standards and formed a Working Group comprising 23 experts in AF/AFL and catheter ablation registries, as well as representatives from the European Heart Rhythm Association and EuroHeart. We conducted a systematic literature review of AF/AFL and catheter ablation registries and data standard documents to generate candidate variables. We used a modified Delphi method to reach a consensus on a final variable set. For each variable, the Working Group developed permissible values and definitions, and agreed as to whether the variable was mandatory (Level 1) or additional (Level 2). In total, 70 Level 1 and 92 Level 2 variables were selected and reviewed by a wider Reference Group of 42 experts from 24 countries. The Level 1 variables were implemented into the EuroHeart IT platform as the basis for continuous registration of individual patient data. Conclusion: By means of a structured process and working with international stakeholders, harmonized data standards for AF/AFL and catheter ablation for AF/AFL were developed. In the context of the EuroHeart project, this will facilitate country-level quality of care improvement, international observational research, registry-based RCTs, and post-marketing surveillance of devices and pharmacotherapies.
UR - http://www.scopus.com/inward/record.url?scp=85170717244&partnerID=8YFLogxK
U2 - 10.1093/ehjqcco/qcac068
DO - 10.1093/ehjqcco/qcac068
M3 - Journal articles
C2 - 36243903
AN - SCOPUS:85170717244
SN - 2058-5225
VL - 9
SP - 609
EP - 620
JO - European Heart Journal - Quality of Care and Clinical Outcomes
JF - European Heart Journal - Quality of Care and Clinical Outcomes
IS - 6
ER -